Department of Research and Development, Orion Pharma Orion Corporation, Espoo, Finland
Department of Research and Development, Orion Pharma Orion Corporation, Espoo, Finland.
Vet Rec. 2020 Mar 7;186(9):283. doi: 10.1136/vr.104953. Epub 2019 Aug 13.
There is a need for an effective and safe emetic agent that dog owners could easily administer to their dogs following veterinary advice in cases of potential poisoning. As a response to this need, a randomised, double-blind, multi-site, clinical field study was performed to assess the efficacy, safety and usability of ropinirole eye drops to induce vomiting in dogs. Ropinirole (target dose 3.75 mg/m) was applied to eyes of 100 dogs, and 32 dogs received placebo. The drug was administered by the dog owner at a veterinary clinic under the supervision of a veterinarian and led to vomition in 95% of the ropinirole-treated dogs within 30 min. The median time to first vomit was 10 min (range: 3-37 min). None of the dogs receiving placebo vomited in this time period. All owners were able to administer the product and 96% of them assessed the administration to be very easy or easy, which was confirmed by the observing veterinarian. Some ocular signs were seen both with ropinirole and placebo, hyperaemia being the most common. All observed signs were transient and in most cases mild. Ropinirole eye drops provided an effective, safe and reliable means to induce emesis in dogs.
需要有一种有效且安全的催吐剂,以便在兽医建议下,狗主人能够轻松地给他们的狗使用,以防潜在的中毒。为了满足这一需求,进行了一项随机、双盲、多地点、临床现场研究,以评估罗匹尼罗滴眼液在诱导犬呕吐方面的疗效、安全性和易用性。给 100 只狗的眼睛滴了罗匹尼罗(目标剂量 3.75mg/m),32 只狗接受了安慰剂。药物由狗主人在兽医诊所,在兽医的监督下使用,结果 95%接受罗匹尼罗治疗的狗在 30 分钟内出现呕吐。首次呕吐的中位数时间为 10 分钟(范围:3-37 分钟)。在此期间,没有一只接受安慰剂的狗呕吐。所有的主人都能够使用该产品,96%的人认为使用非常容易或容易,这也得到了观察兽医的证实。罗匹尼罗和安慰剂都出现了一些眼部症状,其中最常见的是充血。所有观察到的症状都是短暂的,大多数情况下是轻微的。罗匹尼罗滴眼液为诱导犬呕吐提供了一种有效、安全和可靠的方法。